SCHEMBL23682482

SCHEMBL23682482

C=CCC(C)NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@@H](N)C(C)C

nearest known ligand 0.35

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 2/20 0.35
▸ DPP8 Q6V1X1 2/20 0.35
▸ DPP9 Q86TI2 2/20 0.35
▸ DPP7 Q9UHL4 2/20 0.35
▸ NPY4R P50391 9/20 0.35
▸ NPY1R P25929 7/20 0.35
▸ NMT2 O60551 1/20 0.33
▸ NMT1 P30419 1/20 0.33
▸ NPY5R Q15761 6/20 0.33
▸ NPY2R P49146 3/20 0.33
▸ SIRT5 Q9NXA8 1/20 0.33
▸ FAP Q12884 1/20 0.33
▸ DDAH1 O94760 1/20 0.32
▸ C3AR1 Q16581 1/20 0.31
▸ KISS1R Q969F8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21323139 0.83 DPP4 (0.40) DPP4DPP8DPP9DPP7NPY4R
SCHEMBL21137521 0.82 DPP4 (0.40) DPP4DPP8DPP9DPP7NPY4R
SCHEMBL29233240 0.81 DPP4 (0.39) DPP4DPP8DPP9DPP7NPY4R
SCHEMBL19450715 0.81 DPP7 (0.40) DPP4DPP8DPP9DPP7NPY4R
SCHEMBL20385917 0.81 DPP7 (0.40) DPP4DPP8DPP9DPP7NPY4R
SCHEMBL23394645 0.81 DPP7 (0.40) DPP4DPP8DPP9DPP7NPY4R
SCHEMBL21233231 0.81 DPP4 (0.40) DPP4DPP8DPP9DPP7NPY4R
SCHEMBL22797764 0.81 DPP4 (0.42) DPP4DPP8DPP9DPP7NPY4R
SCHEMBL20795868 0.81 DPP4 (0.42) DPP4DPP8DPP9DPP7NPY4R
SCHEMBL22848364 0.81 DPP4 (0.42) DPP4DPP8DPP9DPP7NPY4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220177885-A1 ENDOSOMAL CLEAVABLE LINKERS ALNYLAM PHARMACEUTICALS, INC. (US) 2022-06-09 — — US disclosed
WO-2021151031-A1 PROTEIN-ANTIVIRAL COMPOUND CONJUGATES REGENERON PHARMACEUTICALS, INC. (US) 2021-07-29 — — WO disclosed
Send feedback